Transplant diagnostic is the method used to diagnose the compatibility of the replaced organ. Organ transplantation is a medical procedure in which an organ is removed from the one boy and placed in other body to swap the damaged or missing organ. Kidney is the most widely transplanted organ across the world. Global transplant diagnostics market is driven by increasing number of transplantation procedures across the globe. Increasing prevalence of chronic diseases, advanced in the diagnostic methods and increasing healthcare expenditure has also contributed in the growth of the market. On other hand, limited number of donor and high cost of diagnostic method has hamper the growth of the market. Global transplant diagnostics market is expected to grow at a CAGR of 7.2% during forecasted period.

Segmentation:Global transplant diagnostics market is segmented on the basis of products into instrument, reagent, software and services. On the basis of technology the market is segmented into non-molecular assay and molecular assay. Non-molecular is further segmented into serological assay and mixed lymphocyte culture. Molecular assay is further segmented into sequenced base and PCR based. On the basis of application the market is segmented into heart, lungs, liver, kidney and other. On the basis of method type the market is segmented into pre-transplant screening and post-transplant screening and on the basis of end user the market is segmented as hospitals, transplants centers, research laboratories and other.

Thermo Fisher Scientific, Inc is American multinational company headquartered in US. Thermo Fisher Scientific, Inc. holds the first position in the global transplant diagnostics market. Company has introduces different antibody, HLA Transplant Diagnostics Products, transplant-related biomarker and many more. Electro-Fast and OWL Centipede systems and DNA Isolation Kit are the products of the company. SeCore one of the product for high-resolution HLA typing products. Company has introduced PlexMark which is a highly specific assay with extremely low cross-reactivity perform during renal transplants. Bio-Rad Laboratories, Inc. is the US headquartered company which develops, manufacture and market the wide range of products for clinical diagnostics and research. In Feb 2016, company has got approval for the QX200, Droplet Digital PCR System which are the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic equipment.

Regional AnalysisGeographically, America dominated the global transplant diagnostics market. Increasing demand for the advanced techniques and diagnostic tools and higher healthcare expenditure are the major factor for the growth of the America market. Europe is the second largest transplant diagnostics market which is followed by Asia Pacific. Asia pacific is the fastest growing region for this market. Large population pole suffering from chronic diseases is the major driving factor for the Asia Pacific market.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.